Department of the Army. 2008. Nuclear and Chemical Weapons and Materiel: Biological Surety. Regulation 50–1. Washington, DC: Department of the Army.

Department of State. 2009a. UN Security Council Resolution 1540. Available at <>.

Department of State. 2009b. State Sponsors of Terrorism. Available at <>.

DHB (Defense Health Board). 2009. Defense Health Board Task Force Review of the Department of Defense Biodefense Infrastructure and Biological Research Portfolio. Memorandum for the Surgeon General of the Army. April 29. Available at <>.

DOJ (Department of Justice). 2006. The Attorney General’s Report on Criminal History Background Checks. Available at <>.

DSB (Defense Science Board). 2009. Department of Defense Biological Safety and Surety Program. Available at <>.

Ekboir, Javier M. 1999. Potential Impact of Foot-and-Mouth Disease in California: The Role and Contribution of Animal Health Surveillance and Monitoring Services. Davis, CA: Agricultural Issues Center, Division of Agriculture and Natural Resources, University of California, Davis.

FASEB (Federation of American Societies for Experimental Biology). 2009. FASEB Statement on Dual Use Research and Biosecurity Education. March 5. Available at <>.

FASEB and AAMC (Association of American Medical Colleges). 2009. Letter to U.S. Working Group on Strengthening the Biosecurity of the United States. May 29, 2006. Available at <> and <>.

FBI (Federal Bureau of Investigation). 2008. Science Briefing on the Anthrax Investigation: Opening Statement by Dr. Vahid Majidi. Available at <>.

Fein, Robert A., Bryan Vossekuil, and Gwen A. Holden. 1995. Threat Assessment: An Approach to Prevent Targeted Violence. Washington, DC: National Institute of Justice.

Fein, Robert A., and Bryan Vossekuil. 2009. Presentation to the Committee. June 29.

Fischer, Julie E. 2006. Stewardship or Censorship? Balancing Biosecurity, the Public’s Health, and the Benefits of Scientific Openness. Washington, DC: The Henry L. Stimson Center.

GAO (Government Accountability Office). 2007. High-Containment Biosafety Laboratories: Preliminary Observations on the Oversight of the Proliferation of BSL-3 and BSL-4 Laboratories in the United States. GAO-08-108T. Testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, U.S. House of Representatives.

GAO. 2008. Biosafety Laboratories: Perimeter Security Assessment of the Nation’s Five BSL-4 Laboratories. GAO-08-1092. Washington, DC: GAO.

GAO. 2009a. Biosafety Laboratories: BSL-4 Laboratories Improved Perimeter Security Despite Limited Action by CDC. GAO-09-851. Washington, DC: GAO.

GAO. 2009b. Personnel Security Clearances: An Outcome-Focused Strategy Is Needed to Guide Implementation of the Reformed Clearance Process. GAO-09-488. Washington, DC: GAO.

GAO. 2009c. High-Containment Laboratories: National Strategy for Oversight Is Needed. GAO-09-574. Washington, DC: GAO.

George, Alexander L., and Andrew Bennett. 2005. Case Studies and Theory Development in the Social Sciences. Cambridge, MA: The MIT Press.

Gottron, Frank, and Dana Shea. 2009. Oversight of High-Containment Biological Laboratories: Issues for Congress. Washington, DC: Congressional Research Service.

Gronvall, Gigi Kwik. 2008. Improving the Select Agent Program. Bulletin of the Atomic Scientists. Web Edition (October 29). Available at <>.

The National Academies of Sciences, Engineering, and Medicine
500 Fifth St. N.W. | Washington, D.C. 20001

Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement